Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.100 Biomarker phenotype BEFREE Outcomes were also assessed in patients with diabetes and/or hyperglycemia (impaired glucose tolerance [IGT] and diabetes population [IGT-diabetes population]) and all patients included in the 3 studies (intention-to-treat [ITT] population). 30025392 2019
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.100 Biomarker phenotype BEFREE The adjusted mean GMV, when compared with the NGT group (584 ml [95% CI: 581 to 587]), was significantly lower in the groups i-IFG (578 ml [95% CI: 573 to 582]; p = 0.035) and UDM (562 ml [95% CI: 551 to 573]; p < 0.001), but not different in the i-IGT (586 ml [95% CI: 576 to 596]; p = 0.688) and IFG + IGT (579 ml [95% CI: 571 to 586]; p = 0.209) groups. 29162362 2017
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.100 Biomarker phenotype BEFREE RHR levels were significantly higher in the subjects with isolated impaired fasting glucose (i-IFG), isolated impaired glucose tolerance (i-IGT), IFG + IGT and diabetes than in those with normal glucose regulation. 28903724 2017
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.100 GeneticVariation phenotype BEFREE The purpose was to determine whether lifestyle interventions have different effects on regional fat in women with normal glucose tolerance vs. impaired glucose tolerance (NGT vs. IGT). 28595173 2017
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.100 GeneticVariation phenotype BEFREE The 876 Nordic women with PCOS, aged 14-57 years, were examined for T2D and prediabetes (impaired glucose tolerance [IGT] or impaired fasting glucose (IFG) by OGTT. 29040530 2017
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.100 GeneticVariation phenotype BEFREE Among the total of 142 participants, 73 subjects with no family history of T2DM (FH-) included 42 with normal glucose tolerance (NGT/FH-) and 31 with impaired glucose tolerance (IGT/FH-); and 69 first-degree relatives of patients with T2DM (FH+) included 36 with NGT (NGT/FH+) and 33 with IGT (IGT/FH+). 22543593 2013
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.100 GeneticVariation phenotype BEFREE To explore the clinical significance of seven diabetes-related serum microRNAs (miR-9, miR-29a, miR-30d, miR34a, miR-124a, miR146a and miR375) during the pathogenesis of type 2 diabetes (T2D), 56 subjects were recruited to this study: 18 cases of newly diagnosed T2D (n-T2D) patients, 19 cases of pre-diabetes individuals (impaired glucose tolerance [IGT] and/or impaired fasting glucose [IFG]) and 19 cases of T2D-susceptible individuals with normal glucose tolerance (s-NGT). 20857148 2011
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.100 Biomarker phenotype BEFREE A total of 447 subjects originating from four independent studies in the Netherlands and Germany (256 with normal glucose tolerance [NGT]/191 with impaired glucose tolerance [IGT]) underwent a hyperglycemic clamp. 19808892 2010
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.100 GeneticVariation phenotype BEFREE The studied group consisted of 51 patients with PC (34 with impaired glucose tolerance-IGT, 17 without IGT), 34 type 2 DM and 154 controls. 20398646 2010
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.100 GeneticVariation phenotype BEFREE OGTT data from 551 subjects (485 with normal glucose tolerance [NGT] and 66 with impaired glucose tolerance [IGT]) were analyzed. 12663568 2003
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.100 Biomarker phenotype BEFREE We studied the effect of a low-grade short- and long-term 20% Intralipid infusion (0.4 mL(-1) x kg(-1) x h(-1)) on insulin secretion and insulin action in 15 elderly obese men; 7 glucose intolerant first-degree relatives of type 2 diabetic patients (impaired glucose tolerance [IGT] relatives) and 8 healthy controls of similar age and body mass index (BMI). 12870166 2003
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.100 GeneticVariation phenotype BEFREE Of the case subjects, 23% were glucose intolerant (4% with diabetes and 19% with impaired glucose tolerance [IGT]) compared with 6.5% (all with IGT) of control subjects (P = 0.02). 11128348 2000